Your browser doesn't support javascript.
loading
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
Gillooly, Kathleen M; Pulicicchio, Claudine; Pattoli, Mark A; Cheng, Lihong; Skala, Stacey; Heimrich, Elizabeth M; McIntyre, Kim W; Taylor, Tracy L; Kukral, Daniel W; Dudhgaonkar, Shailesh; Nagar, Jignesh; Banas, Dana; Watterson, Scott H; Tino, Joseph A; Fura, Aberra; Burke, James R.
Afiliação
  • Gillooly KM; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Pulicicchio C; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Pattoli MA; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Cheng L; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Skala S; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Heimrich EM; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • McIntyre KW; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Taylor TL; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Kukral DW; Exploratory Clinical and Translational Research, Imaging, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Dudhgaonkar S; Disease Sciences and Technology, Biocon Bristol-Myers Squibb Research Center, Syngene International Limited, Bangalore, India.
  • Nagar J; Disease Sciences and Technology, Biocon Bristol-Myers Squibb Research Center, Syngene International Limited, Bangalore, India.
  • Banas D; Discovery Translational Sciences, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Watterson SH; Immunosciences Discovery Chemistry, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Tino JA; Immunosciences Discovery Chemistry, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Fura A; Department of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
  • Burke JR; Immunosciences Discovery Biology, Bristol-Myers Squibb Research & Development, Princeton, New Jersey, United States of America.
PLoS One ; 12(7): e0181782, 2017.
Article em En | MEDLINE | ID: mdl-28742141
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Experimental / Proteínas Tirosina Quinases / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Experimental / Proteínas Tirosina Quinases / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos